Pabatang, Zedric Angelo .
HRN: 21-82-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2023
CEFUROXIME 1.5GM (VIAL)
12/17/2023
12/23/2023
IV
366mg
Q8
UTI; Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes